7Z5W
ROS1 with AstraZeneca ligand 1
Summary for 7Z5W
Entry DOI | 10.2210/pdb7z5w/pdb |
Descriptor | Proto-oncogene tyrosine-protein kinase ROS, ~{N}-[6-methyl-2-[(2~{S})-2-[3-(3-methylpyrazin-2-yl)-1,2-oxazol-5-yl]pyrrolidin-1-yl]pyrimidin-4-yl]-1,3-thiazol-2-amine, SULFATE ION, ... (4 entities in total) |
Functional Keywords | virtual screening, potent selective, ros1, kinase inhibitors, transferase |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 2 |
Total formula weight | 76335.01 |
Authors | Hargreaves, D. (deposition date: 2022-03-10, release date: 2022-08-17, Last modification date: 2024-01-31) |
Primary citation | Petrovic, D.,Scott, J.S.,Bodnarchuk, M.S.,Lorthioir, O.,Boyd, S.,Hughes, G.M.,Lane, J.,Wu, A.,Hargreaves, D.,Robinson, J.,Sadowski, J. Virtual Screening in the Cloud Identifies Potent and Selective ROS1 Kinase Inhibitors. J.Chem.Inf.Model., 62:3832-3843, 2022 Cited by PubMed: 35920716DOI: 10.1021/acs.jcim.2c00644 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.254 Å) |
Structure validation
Download full validation report